Skip to main content
. 2021 Feb 22;23(2):e26257. doi: 10.2196/26257

Table 2.

Univariable analysis for potential factors associated with overall survival in the development cohort. All values presented in the table represent data collected at the time of initial COVID-19 diagnosis.

Factor Number of patients (n=3729), n (%) Overall survival rate, % (95% CI) P value
At 14 days At 28 days
Age (years) <.001

<50 1782 (47.8) 99.9 (99.8-100) 99.8 (99.5-100)


50-69 1373 (36.8) 98.6 (98-99.2) 98 (97.2-98.8)


≥70 574 (15.4) 87 (84.3-89.8) 81.6 (78.3-85)

Sex .01

Female 2193 (58.8) 97.8 (97.2-98.4) 96.8 (96-97.6)


Male 1536 (41.2) 96.9 (96-97.8) 95.2 (94.1-96.4)

Comorbidity

Hypertension <.001


No 2932 (78.6) 98.7 (98.3-99.1) 98 (97.4-98.6)



Yes 795 (21.3) 92.7 (90.9-94.6) 89.7 (87.4-91.9)


Diabetes <.001


No 3275 (87.8) 98.3 (97.8-98.7) 97.3 (96.7-98)



Yes 452 (12.1) 91.5 (88.9-94.1) 88.1 (85-91.3)


Dementia <.001


No 3359 (90.1) 98.3 (97.9-98.7) 97.3 (96.7-97.9)



Yes 150 (4) 74.5 (67.8-81.8) 67.4 (60.1-75.6)


Chronic cardiac disease a <.001


No 3582 (96.1) 97.7 (97.2-98.2) 96.7 (96-97.3)



Yes 147 (3.9) 91.1 (86.6-95.8) 85.8 (79.9-92)


Cancer in active treatment .03


No 3636 (97.5) 97.5 (97-98) 96.3 (95.7-97)



Yes 90 (2.4) 95.5 (91.2-99.9) 89.8 (82.5-97.7)


Chronic pulmonary disease b <.001


No 3628 (97.3) 97.6 (97.1-98.1) 96.5 (95.9-97.2)



Yes 101 (2.7) 92 (86.8-97.5) 85.3 (77.9-93.3)


Chronic hepatic disease .6


No 3463 (92.9) 97.3 (96.7-97.8) 96 (95.2-96.7)



Yes 47 (1.3) 97.9 (93.8-100) 95.3 (89.1-100)


Chronic renal failure <.001


No 3691 (99) 97.5 (97-98) 96.3 (95.7-97)



Yes 36 (1) 85.7 (74.9-98.1) 81.2 (68.4-96.4)


Autoimmune disease .56


No 3476 (93.2) 97.3 (96.7-97.8) 96 (95.3-96.7)



Yes 31 (0.8) 96.8 (90.8-100) 90.7 (78.7-100)

Symptoms


Sputum .59


No 2612 (70) 97.4 (96.8-98.1) 96 (95.2-96.9)



Yes 1114 (29.9) 97.4 (96.4-98.3) 96.5 (95.4-97.7)


Dyspnea <.001


No 3272 (87.7) 98.3 (97.9-98.8) 97.4 (96.8-98)



Yes 454 (12.2) 90.9 (88.2-93.6) 87.6 (84.4-90.9)


Diarrhea .81


No 3381 (90.7) 97.4 (96.8-97.9) 96.1 (95.4-96.8)



Yes 345 (9.3) 98 (96.5-99.5) 96.8 (94.8-98.8)


Nausea/vomiting .2


No 3558 (95.4) 97.5 (97-98.1) 96.3 (95.6-97)



Yes 168 (4.5) 95.1 (91.8-98.5) 94.3 (90.8-98)


Fatigue .006


No 3562 (95.5) 97.5 (97-98.1) 96.4 (95.7-97.1)



Yes 164 (4.4) 95 (91.7-98.5) 91.9 (87.6-96.5)


Mental disturbance <.001


No 3704 (99.3) 97.7 (97.3-98.2) 96.5 (95.9-97.2)



Yes 22 (0.6) 45.5 (28.8-71.8) 40.4 (24.2-67.5)

Systolic blood pressure (mmHg) .02

<140 2345 (62.9) 97.8 (97.2-98.4) 96.8 (96-97.6)


≥140 1290 (34.6) 96.9 (95.9-97.9) 95.3 (94-96.6)

Diastolic blood pressure (mmHg) .01

<80 1401 (37.6) 96.7 (95.7-97.6) 94.9 (93.7-96.2)


≥80 2234 (59.9) 98 (97.4-98.6) 97.1 (96.3-97.8)

Heart rate (per min) .005

<110 3374 (90.5) 97.7 (97.2-98.2) 96.4 (95.7-97.1)


≥110 272 (7.3) 94.4 (91.6-97.2) 93.5 (90.6-96.6)

Body temperature (°C) <.001

<38 3523 (94.5) 97.8 (97.3-98.3) 96.4 (95.8-97.1)


≥38 179 (4.8) 93.2 (89.6-97) 93.2 (89.6-97)

Baseline hemogram


Hemoglobin (g/dL) <.001

≥12.5 1923 (51.6) 97.9 (97.2-98.5) 96.8 (95.9-97.7)


<12.5 773 (20.7) 93.6 (91.8-95.3) 90.8 (88.7-93.1)


Absolute lymphocyte count (per mm 3 ) <.001

≥1000 2161 (58) 98.3 (97.8-98.9) 97.7 (97-98.4)


<1000 518 (13.9) 89.7 (87.1-92.4) 84.3 (81-87.8)


Platelet count (per mm 3 ) <.001

≥100,000 2634 (70.6) 96.9 (96.2-97.5) 95.2 (94.3-96.1)


<100,000 62 (1.7) 85.3 (76.9-94.7) 83.5 (74.7-93.4)

aChronic cardiac disease was a composite variable including heart failure and cardiac disease.

bChronic pulmonary disease was a composite variable including asthma and chronic obstructive lung disease.